TY - JOUR
T1 - Effectiveness of myAirCoach
T2 - a mHealth self-management system in asthma
AU - Khusial, Rishi J
AU - Honkoop, Persijn J
AU - Usmani, Omar
AU - Soares, Marcia
AU - Simpson, Andrew
AU - Biddiscombe, Martyn
AU - Meah, Sally
AU - Bonini, Matteo
AU - Lalas, Antonios
AU - Polychronidou, Eleftheria
AU - Koopmans, Julia G
AU - Moustakas, Kostas
AU - Snoeck-Stroband, Jiska B
AU - Ortmann, Steffen
AU - Votis, Konstantinos
AU - Tzovaras, Dimitrios
AU - Chung, Kian Fan
AU - Fowler, Stephen
AU - Sont, Jacob K
N1 - Copyright © 2020. Published by Elsevier Inc.
PY - 2020
Y1 - 2020
N2 - BACKGROUND: Self-management programs have beneficial effects on asthma control, but their implementation in clinical practice is poor. Mobile health (mHealth) could play an important role in enhancing self-management.OBJECTIVE: To assess the clinical effectiveness and technology acceptance of myAirCoach supported self-management on top of usual care in asthma patients using inhalation medication .METHODS: Patients were recruited in two separate studies. The myAirCoach system consisted of an inhaler adapter, an indoor air-quality monitor, a physical activity tracker, a portable spirometer, a Fraction exhaled Nitric Oxide (FeNO) device and an app. The primary outcome was asthma control; secondary outcomes were exacerbations, quality of life, and technology acceptance. In study 1, 30 participants were randomized to either usual care or myAirCoach support for 3-6 months; in study 2, 12 participants were provided with the myAirCoach system in a 3 month before-after study.RESULTS: In study 1 asthma control improved in the intervention group compared to controls (ACQ difference 0.70, p=0.006). A total of six exacerbations occurred in the intervention group compared to 12 in the control group (hazard ratio 0.31, p=0.06). Asthma related quality of life improved (m-AQLQ difference 0.53, p= 0.04), but FEV1 was unchanged. In study 2, asthma control improved by 0.86 compared to baseline (p=0.007) and quality of life by 0.16 (p=0.64). Participants reported positive attitudes towards the system.DISCUSSION: Using the myAirCoach support system improves asthma control and quality of life, with a reduction in severe asthma exacerbations. Well validated mHealth technologies should therefore be further studied.
AB - BACKGROUND: Self-management programs have beneficial effects on asthma control, but their implementation in clinical practice is poor. Mobile health (mHealth) could play an important role in enhancing self-management.OBJECTIVE: To assess the clinical effectiveness and technology acceptance of myAirCoach supported self-management on top of usual care in asthma patients using inhalation medication .METHODS: Patients were recruited in two separate studies. The myAirCoach system consisted of an inhaler adapter, an indoor air-quality monitor, a physical activity tracker, a portable spirometer, a Fraction exhaled Nitric Oxide (FeNO) device and an app. The primary outcome was asthma control; secondary outcomes were exacerbations, quality of life, and technology acceptance. In study 1, 30 participants were randomized to either usual care or myAirCoach support for 3-6 months; in study 2, 12 participants were provided with the myAirCoach system in a 3 month before-after study.RESULTS: In study 1 asthma control improved in the intervention group compared to controls (ACQ difference 0.70, p=0.006). A total of six exacerbations occurred in the intervention group compared to 12 in the control group (hazard ratio 0.31, p=0.06). Asthma related quality of life improved (m-AQLQ difference 0.53, p= 0.04), but FEV1 was unchanged. In study 2, asthma control improved by 0.86 compared to baseline (p=0.007) and quality of life by 0.16 (p=0.64). Participants reported positive attitudes towards the system.DISCUSSION: Using the myAirCoach support system improves asthma control and quality of life, with a reduction in severe asthma exacerbations. Well validated mHealth technologies should therefore be further studied.
U2 - 10.1016/j.jaip.2020.02.018
DO - 10.1016/j.jaip.2020.02.018
M3 - Article
C2 - 32142961
JO - The journal of allergy and clinical immunology. In practice
JF - The journal of allergy and clinical immunology. In practice
SN - 2213-2201
ER -